• BX Home
  • Allergan Inc.: News [Page 9]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

ALLERGAN INC.

Allergan, Inc. is a global, multi-specialty healthcare company that operates in two business segments: specialty pharmaceuticals and medical devices. Their products include ophthalmic pharmaceuticals, dermatology products, and neurological products. Allergan, Inc.’s most notable product is Botox, which is used for therapeutic and aesthetic indications. The company was founded in 1948 and is headquartered in Irvine, California.

Allergan Inc. is part of Business Exchange, suggested by Ulli Muenker. This topic contains 244 news and 82 blog items. Read updated news, blogs, and resources about Allergan Inc.. Find user-submitted articles and reactions on Allergan Inc. from like-minded professionals.

News

Recent news on this topic.

Madoff begins 150-year prison sentencemore

of 43 cents a share. Revenue fell about 7% to $2.5 billion. DRUGS Allergan sues rival Watson Allergan Inc.

Revance Therapeutics Announces Efficacy of Topical Botulinum Toxin Typ...more

for its topical and injectable neurologic compounds and TransMTS delivery technology. Botox® Cosmetic is a registered...

U.S. FDA advisory meetings through Aug 13more

Solvay SA's (SOLB.BR) testosterone gel Androgel, Schering-Plough Corp's asthma drug (SGP.N) Asmanex (mometasone...

Ozurdex Implant Approved for Macular Edemamore

-- swells because of fluid accumulation from leaking or blocked retinal veins. In a news release, device maker...

Allergan wins FDA approval for eye treatmentmore

BOSTON (MarketWatch) -- Allergan Inc. (agn) said Thursday that it has won U.S. regulatory approval for its eye...

Maguire sells Irvine office building at a lossmore

Among other recent sales, the Southern California-focused real estate investment trust completed a $22-million...

VIDEO: Allergan, Inc. Announces the 'BOTOX(R) Cosmetic: Express Succes...more

VIDEO: Allergan, Inc. Announces the 'BOTOX(R) Cosmetic: Express Success' Charitable Education Campaign, Committing...

Allergan leads drug stocks highermore

Drug stocks climbed into positive territory with the broader market early Monday, with Allergan Inc. blazing the trail.

Drug stocks climb; Allergan on reboundmore

to portfolio Analyst Create alert Insider Discuss Financials Sponsored by: , , ) was up about 60 points at 8,273.

Allergan's profit falls 58% as recession slows Botox salesmore

Allergan Inc., maker of the wrinkle-smoother Botox, reported Friday that its first-quarter profit fell 58% as the...

CORRECTED - UPDATE 1-Allergan profit falls; Botox, device sales plungemore

Botox sales fall 5.8 percent * Total revenue down 6 percent NEW YORK, May 1 (Reuters) - Allergan Inc (AGN.

Allergan 1Q profit falls on charges, sales dropmore

IRVINE, Calif. - Botox maker Allergan Inc. said Friday its first-quarter profit fell 59 percent on a series of...

BIOCOM's 4th Annual DeviceFest and Exhibitionmore

Key Note Speaker: Robert E. Grant, President, Allergan Medical Mr. Robert E. Grant, 39, joined Allergan, Inc.

Allergan profit falls; Botox, device sales plungemore

* Botox sales fall 18 percent * Total revenue down 6 percent NEW YORK (Reuters) - Allergan Inc said Friday its...

UPDATE 2-Botox must carry strong warning on risks-U.S. FDAmore

reported * Allergan shares fall 2.6 percent (Adds FDA quotes, updates shares) WASHINGTON, April 30 (Reuters) - Allergan...

FDA toughens warnings on Botox-like productsmore

affected users had taken the drug to treat limb spasticity associated with cerebral palsy. Botox is marketed by...

Three more pharma megamergers to go?more

NYSE:SNY) and Novartis, but we should not rule out (NYSE: JNJ) or GlaxoSmithKline, if its acquisition of Allergan Inc.

Drug stocks flee into negative territorymore

Industrial Average tumbled about 240 points, or 3%, to 7,892. Leading decliners among the large caps included Allergan...

UPDATE: US Drug Stocks Flee Into Negative Territorymore

Industrial Average tumbled about 240 points, or 3%, to 7,892. Leading decliners among the large caps included Allergan...

ThermoGenesis Names 30-Year Healthcare Industry Executive J. Melville ...more

at Dey, Engle also served as Regional Director, North America, for the Merck Generics Group. He was with Allergan, Inc.

Research and Markets: Global Strategic Analysis of the US and the Euro...more

Liposuction, Blepharoplasty, and Rhinoplasty. The report profiles 78 companies including many key and niche players...

Allergan Announces Quarterly Conference Callmore

IRVINE, Calif.--(Business Wire)-- Allergan, Inc. (NYSE:AGN) invites you to listen to David Pyott, Chairman of the Board...

Spectrum Pharmaceuticals Announces Fiscal Year 2008 Corporate Update a...more

is a registered trademark of RIT Oncology LLC, a subsidiary of Spectrum. EOquin is a registered trademark of Allergan,...

Video: Allergan Announces the LATISSE(TM) Wishes Campaign, Committing ...more

Foundation(R) Register on LATISSE(TM) Web Site to Help Reach Goal IRVINE, Calif., March 27 /PRNewswire-FirstCall/ --...

Allergan shares jump 13% on takeover speculationmore

Shares of Allergan Inc. rose 13% on Tuesday on speculation the maker of Botox might be bought. Allergan surged $5.

Top Sources: Allergan Inc.

  • grinza.com
  • Reuters
  • MarketWatch
  • TheDeal.com
  • ocbj.com
  • BusinessWeek
  • Wall Street Journal Online
  • Los Angeles Times
  • Morningstar.com
  • CNN Money

Most Active Users in this Topic

see all contributors in Allergan Inc.

Featured White Papers

Post a Job

Jobs in this Topic

Programmer, Principle Allergan | Bedminster, NJ
Posted: Apr 16
Neuroscience Specialist - Toronto Allergan | San Francisco, CA
Posted: May 21
Demand Planner Allergan | San Francisco, CA
Posted: May 21
Research and Scientific Services Manager (Medical Scientific Liaison) Allergan | San Francisco, CA
Posted: May 21
Region Manager - Topical Aesthetics - Southeast Allergan | San Francisco, CA
Posted: May 21

Report comment contains invalid characters. ()
cancel
Search Cancel